Baird analyst Brian Skorney raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $0.55 (from $0.50) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE